STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity.
Aaron R CoxNatasha ChernisDavid A BaderPradip K SahaPeter M MasschelinJessica B FelixRobert SharpZeqin LianVasanta PutluriKimal RajapaksheKang Ho KimDennis T VillarealReina Armamento-VillarealHuaizhu WuCristian CoarfaNagireddy PutluriSean M HartigPublished in: Diabetes (2020)
Obesity fosters low-grade inflammation in white adipose tissue (WAT) that may contribute to the insulin resistance that characterizes type 2 diabetes. However, the causal relationship of these events remains unclear. The established dominance of STAT1 function in the immune response suggests an obligate link between inflammation and the comorbidities of obesity. To this end, we sought to determine how STAT1 activity in white adipocytes affects insulin sensitivity. STAT1 expression in WAT inversely correlated with fasting plasma glucose in both obese mice and humans. Metabolomic and gene expression profiling established STAT1 deletion in adipocytes (STAT1 a-KO ) enhanced mitochondrial function and accelerated tricarboxylic acid cycle flux coupled with reduced fat cell size in subcutaneous WAT depots. STAT1 a-KO reduced WAT inflammation, but insulin resistance persisted in obese mice. Rather, elimination of type I cytokine interferon-γ activity enhanced insulin sensitivity in diet-induced obesity. Our findings reveal a permissive mechanism that bridges WAT inflammation to whole-body insulin sensitivity.
Keyphrases
- insulin resistance
- adipose tissue
- high fat diet induced
- type diabetes
- high fat diet
- oxidative stress
- metabolic syndrome
- cell proliferation
- low grade
- polycystic ovary syndrome
- skeletal muscle
- immune response
- genome wide
- glycemic control
- weight loss
- high grade
- weight gain
- cardiovascular disease
- single cell
- stem cells
- poor prognosis
- toll like receptor
- blood pressure
- copy number
- mesenchymal stem cells
- bone marrow
- blood glucose
- inflammatory response
- body mass index
- fatty acid
- genome wide analysis